1-6 of 6
Katsutoshi Ozaki, MD
Close
Sort by
Journal Articles

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Yoshitaka Miyakawa, MD, PhD, Shinya Katsutani, MD, PhD, Takahiro Yano, MD, PhD, Shosaku Nomura, MD, PhD, Kaichi Nishiwaki, MD, Yoshiaki Tomiyama, MD, PhD, Masaaki Higashihara, MD, PhD, Yukari Shirasugi, MD, PhD, Masakatsu Nishikawa, MD, PhD, Katsutoshi Ozaki, MD, PhD, Kayoko Kikuchi, Takayuki Abe, PhD, Yuji Sato, MD, PhD, Yuzuru Kanakura, Kingo Fujimura, MD, PhD, Yasuo Ikeda, MD, PhD, Shinichiro Okamoto, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3554.
https://doi.org/10.1182/blood.V122.21.3554.3554
Published: 2013
Journal Articles

Lack of IL-21 Signal Attenuates Graft-Versus-Leukemia Effect In the Absence of CD8 T-Cells.

Katsutoshi Ozaki, MD, PhD, Akiko Meguro, Keiko Hatanaka, Iekuni Oh, Haruko Matsu, Raine Tatara, Kazuya Sato, MD, Warren J Leonard, Keiya Ozawa, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3739.
https://doi.org/10.1182/blood.V116.21.3739.3739
Published: 2010
Journal Articles

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Kazuya Sato, MD, PhD, Katsutoshi Ozaki, MD, PhD, Tomohiro Matsuyama, MD, Ken Ohmine, MD, PhD, Takahiro Suzuki, MD, PhD, Masaki Mori, MD, PhD, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4132.
https://doi.org/10.1182/blood.V116.21.4132.4132
Published: 2010
Journal Articles

Six Month Treatment of Low Dose Eltrombopag Is Efficacious in Japanese Patients with Refractory Chronic Immune Thrombocytopenic Purpura (ITP).

Yoshiaki Tomiyama, MD, Yoshitaka Miyakawa, MD, PhD, Shinichiro Okamoto, MD, PhD, Shinya Katsutani, MD, Akiro Kimura, MD, Yasushi Okoshi, MD, PhD, Haruhiko Ninomiya, MD, PhD, Hiroshi Kosugi, MD, PhD, Shosaku Nomura, MD, Katsutoshi Ozaki, MD, Yasuo Ikeda, MD, Nobuyuki Koh, Koichi Katsura, MD, PhD, Yuzuru Kanakura, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1324.
https://doi.org/10.1182/blood.V114.22.1324.1324
Published: 2009
Journal Articles

Mesenchymal Stem Cells Produce Nitric Oxide, a Key Molecule for T Cell Suppression, upon Interaction with Activated T Cells.

Kazuya Sato, MD, Katsutoshi Ozaki, MD, PhD, Iekuni Oh, MD, PhD, Akiko Meguro, MD, Reine Tatara, MD, Keiko Hatanaka, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2556.
https://doi.org/10.1182/blood.V108.11.2556.2556
Published: 2006
Journal Articles

Mesenchymal Stem Cells (MSCs) Suppress T Cell Proliferation by a Novel NO-stat5 Dependent Mechanism.

Kazuya Sato, MD, Katsutoshi Ozaki, MD, PhD, Iekuni Oh, MD, Keiko Hatanaka, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1393.
https://doi.org/10.1182/blood.V106.11.1393.1393
Published: 2005